{
 "Susceptible": {
 "Drug": {
 "Amikacin": {
 "State": {
 "State": [ "N/A" ],
"percentage": [      100 ] 
},
"Gender": {
 "Gender": [ "Female" ],
"percentage": [      100 ] 
},
"Age.Group": {
 "Age.Group": [ "19 to 64 Years", "3 to 12 Years" ],
"percentage": [       50,       50 ] 
},
"Speciality": {
 "Speciality": [ "Medicine General", "None Given" ],
"percentage": [       50,       50 ] 
},
"Source": {
 "Source": [ "Bodily Fluids: Abdominal", "GU: Urine" ],
"percentage": [       50,       50 ] 
},
"In...Out.Patient": {
 "In...Out.Patient": [ "Inpatient", "None Given" ],
"percentage": [       50,       50 ] 
} 
},
"Cefepime": {
 "State": {
 "State": [ "N/A" ],
"percentage": [      100 ] 
},
"Gender": {
 "Gender": [ "Female" ],
"percentage": [      100 ] 
},
"Age.Group": {
 "Age.Group": [ "19 to 64 Years", "3 to 12 Years" ],
"percentage": [       50,       50 ] 
},
"Speciality": {
 "Speciality": [ "Medicine General", "None Given" ],
"percentage": [       50,       50 ] 
},
"Source": {
 "Source": [ "Bodily Fluids: Abdominal", "GU: Urine" ],
"percentage": [       50,       50 ] 
},
"In...Out.Patient": {
 "In...Out.Patient": [ "Inpatient", "None Given" ],
"percentage": [       50,       50 ] 
} 
},
"Ceftazidime": {
 "State": {
 "State": [ "N/A" ],
"percentage": [      100 ] 
},
"Gender": {
 "Gender": [ "Female" ],
"percentage": [      100 ] 
},
"Age.Group": {
 "Age.Group": [ "19 to 64 Years" ],
"percentage": [      100 ] 
},
"Speciality": {
 "Speciality": [ "None Given" ],
"percentage": [      100 ] 
},
"Source": {
 "Source": [ "Bodily Fluids: Abdominal" ],
"percentage": [      100 ] 
},
"In...Out.Patient": {
 "In...Out.Patient": [ "None Given" ],
"percentage": [      100 ] 
} 
},
"Ceftriaxone": {
 "State": {
 "State": [ "N/A" ],
"percentage": [      100 ] 
},
"Gender": {
 "Gender": [ "Female" ],
"percentage": [      100 ] 
},
"Age.Group": {
 "Age.Group": [ "19 to 64 Years" ],
"percentage": [      100 ] 
},
"Speciality": {
 "Speciality": [ "None Given" ],
"percentage": [      100 ] 
},
"Source": {
 "Source": [ "Bodily Fluids: Abdominal" ],
"percentage": [      100 ] 
},
"In...Out.Patient": {
 "In...Out.Patient": [ "None Given" ],
"percentage": [      100 ] 
} 
},
"Levofloxacin": {
 "State": {
 "State": [ "N/A" ],
"percentage": [      100 ] 
},
"Gender": {
 "Gender": [ "Female" ],
"percentage": [      100 ] 
},
"Age.Group": {
 "Age.Group": [ "19 to 64 Years", "3 to 12 Years" ],
"percentage": [       50,       50 ] 
},
"Speciality": {
 "Speciality": [ "Medicine General", "None Given" ],
"percentage": [       50,       50 ] 
},
"Source": {
 "Source": [ "Bodily Fluids: Abdominal", "GU: Urine" ],
"percentage": [       50,       50 ] 
},
"In...Out.Patient": {
 "In...Out.Patient": [ "Inpatient", "None Given" ],
"percentage": [       50,       50 ] 
} 
},
"Meropenem": {
 "State": {
 "State": [ "N/A" ],
"percentage": [      100 ] 
},
"Gender": {
 "Gender": [ "Female" ],
"percentage": [      100 ] 
},
"Age.Group": {
 "Age.Group": [ "19 to 64 Years", "3 to 12 Years" ],
"percentage": [       50,       50 ] 
},
"Speciality": {
 "Speciality": [ "Medicine General", "None Given" ],
"percentage": [       50,       50 ] 
},
"Source": {
 "Source": [ "Bodily Fluids: Abdominal", "GU: Urine" ],
"percentage": [       50,       50 ] 
},
"In...Out.Patient": {
 "In...Out.Patient": [ "Inpatient", "None Given" ],
"percentage": [       50,       50 ] 
} 
},
"Minocycline": {
 "State": {
 "State": [ "N/A" ],
"percentage": [      100 ] 
},
"Gender": {
 "Gender": [ "Female" ],
"percentage": [      100 ] 
},
"Age.Group": {
 "Age.Group": [ "19 to 64 Years", "3 to 12 Years" ],
"percentage": [       50,       50 ] 
},
"Speciality": {
 "Speciality": [ "Medicine General", "None Given" ],
"percentage": [       50,       50 ] 
},
"Source": {
 "Source": [ "Bodily Fluids: Abdominal", "GU: Urine" ],
"percentage": [       50,       50 ] 
},
"In...Out.Patient": {
 "In...Out.Patient": [ "Inpatient", "None Given" ],
"percentage": [       50,       50 ] 
} 
},
"Piperacillin tazobactam": {
 "State": {
 "State": [ "N/A" ],
"percentage": [      100 ] 
},
"Gender": {
 "Gender": [ "Female" ],
"percentage": [      100 ] 
},
"Age.Group": {
 "Age.Group": [ "19 to 64 Years", "3 to 12 Years" ],
"percentage": [       50,       50 ] 
},
"Speciality": {
 "Speciality": [ "Medicine General", "None Given" ],
"percentage": [       50,       50 ] 
},
"Source": {
 "Source": [ "Bodily Fluids: Abdominal", "GU: Urine" ],
"percentage": [       50,       50 ] 
},
"In...Out.Patient": {
 "In...Out.Patient": [ "Inpatient", "None Given" ],
"percentage": [       50,       50 ] 
} 
} 
},
"percentage": [ 14.28571, 14.28571, 7.142857, 7.142857, 14.28571, 14.28571, 14.28571, 14.28571 ],
"weight":    0.875,
"backgroundColor": [ "#a6cee3", "#fb9a99", "#fdbf6f", "#ff7f00", "#8dd3c7", "#bebada", "#80b1d3", "#b3de69" ] 
},
"Intermediate": {
 "Drug": {
 "Ceftriaxone": {
 "State": {
 "State": [ "N/A" ],
"percentage": [      100 ] 
},
"Gender": {
 "Gender": [ "Female" ],
"percentage": [      100 ] 
},
"Age.Group": {
 "Age.Group": [ "3 to 12 Years" ],
"percentage": [      100 ] 
},
"Speciality": {
 "Speciality": [ "Medicine General" ],
"percentage": [      100 ] 
},
"Source": {
 "Source": [ "GU: Urine" ],
"percentage": [      100 ] 
},
"In...Out.Patient": {
 "In...Out.Patient": [ "Inpatient" ],
"percentage": [      100 ] 
} 
} 
},
"percentage":      100,
"weight":   0.0625,
"backgroundColor": "#ff7f00" 
},
"Resistant": {
 "Drug": {
 "Ceftazidime": {
 "State": {
 "State": [ "N/A" ],
"percentage": [      100 ] 
},
"Gender": {
 "Gender": [ "Female" ],
"percentage": [      100 ] 
},
"Age.Group": {
 "Age.Group": [ "3 to 12 Years" ],
"percentage": [      100 ] 
},
"Speciality": {
 "Speciality": [ "Medicine General" ],
"percentage": [      100 ] 
},
"Source": {
 "Source": [ "GU: Urine" ],
"percentage": [      100 ] 
},
"In...Out.Patient": {
 "In...Out.Patient": [ "Inpatient" ],
"percentage": [      100 ] 
} 
} 
},
"percentage":      100,
"weight":   0.0625,
"backgroundColor": "#fdbf6f" 
} 
}
